TAS-116 triggered significant degradation of key RAS-RAF-MEK-ERK pathway regulators (p-C-Raf, p-MEK1/2, and p-ERK) in a dose-dependent manner in RAS-mutated MM cell lines (Fig 2B). The gene discussed is MAP2K7; the disease is Miyoshi myopathy.